Lebanon National Drugs Database

عربي

English

روابط سريعة

الروابط

مواقع ذات صلة

Arabic

الخط الساخن للخدمات الصحية للنازحين اللبنانيين 1787

الخط الساخن لوزارة الصحّة العامة 1214

هل أنت مستخدم جديد؟ قم بالتسجيل الآن

تابع معاملاتِك هل انت طبيب ؟

تسجيل الدخول | إنشاء حساب

هل نسيت كلمة السرّ؟

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

173

الكل

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
J07AL02	VAXNEUVANCE	B	Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 22F, 23F,33F (2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg) Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate adjuvant -		Injectable suspension	6,988,413 L.L
J07AP03	TYPHIBEV TYPHOID CONJUGATED VACCINE (MONOVALENT)	B	Salmonella typhi polysaccharides Vi purified - 25mcg of Vi-PS2/0.5ml		Injectable suspension	4,020,777 L.L
J07BB01	INFLUVAC TETRA	B	Influenza virus surface antigens inactivated (haemagglutinin and neuraminidase) - 15mcg/4strains/0.5ml		Injectable suspension	970,254 L.L
J07BB01	VAXIGRIPTETRA, VACCIN GRIPPAL QUADRIVALENT (INACTIVE A VIRION FRAGMENTE)	B	Influenza vaccine virus (inactivated, split) - 15mcg/4strains/0.5ml		Injectable suspension	970,254 L.L
J07BB02	INFLUVAC	B	Grippal virus surface antigen 3strains - 15mcgx3strains/0.5ml		Injectable suspension	573,821 L.L
J07BC01	ENGERIX-B 20	B	Hepatitis B, purified antigen - 20mcg/ml	20mcg/ml	Injectable suspension	1,652,926 L.L
J07BC01	ENGERIX-B 10	B	Hepatitis B, surface antigen - 10mcg/0.5ml	10mcg/0.5ml	Injectable suspension	1,042,822 L.L
J07BC01	HEPATITIS-B VACCINE (r DNA) PAEDIATRIC	G	Hepatitis B, purified surface antigen adsorbed on aluminium hydroxide (Al+++) (0.25mg to 0.40mg) - 10mcg/0.5ml	10mcg/0.5ml	Injectable suspension	323,866 L.L
J07BC02	HAVRIX '1440'	B	Hepatitis A, inactivated, whole virus - 1,440 ELISA units/ml	1,440 ELISA units/ml	Injectable suspension	2,215,996 L.L
J07BC02	HAVRIX JUNIOR 720	B	Hepatitis A, inactivated, whole virus - 720 ELISA units/0.5ml	720 ELISA units/0.5ml	Injectable suspension	1,491,665 L.L
J07BC02	AVAXIM PEDIATRIQUE (vaccin inactivé de l'hépatite A adsorbé)	B	Hepatitis A, inactivated, whole virus - 80 antigen units/0.5ml	80 antigen units/0.5ml	Injectable suspension	1,531,980 L.L
J07BC02	VAQTA	B	Hepatitis A, inactivated, whole virus - 25U/0.5ml	25U/0.5ml	Injectable suspension	2,539,862 L.L
J07BC02	HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED	BioTech	Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 0.5ml/dose	0.5ml/dose	Injectable suspension	1,777,904 L.L
J07BC02	HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED	BioTech	Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 1ml/dose	0.5ml/dose	Injectable suspension	2,257,655 L.L
J07BF03	POLIOMYELITIS VACCINE INACTIVATED	B	Poliomyelitis virus type 1 inactivated - 40D.U, Poliomyelitis virus type 2 inactivated - 8D.U, Poliomyelitis virus type 3 inactivated - 32D.U		Injectable suspension	1,206,771 L.L
J07BK01	VARICELLA VACCINE LIVE	BioTech	Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated -		Injectable suspension	3,104,276 L.L
J07BM03	GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT	B	Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml		Injectable suspension	14,139,396 L.L
J07CA02	TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé)	B	Diphteria toxoid purified - =30IU, Tetanus toxoid purified - =40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg		Injectable suspension	1,628,737 L.L
J07CA09	INFANRIX HEXA	B	Diphteria toxoid purified (Prefilled syringe) - =30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - =40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml		Injectable suspension	4,230,416 L.L
J07CA09	HEXAXIM	BioTech	Diphteria Toxoid - =20IU/0.5ml, Tetanus toxoid - =40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg		Injectable suspension	4,462,901 L.L
J07CA11	DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE	B	Diphteria Toxoid1 - =25Lf (=30IU)/0.5ml, Tetanus toxoid1 - =2.5Lf (=40IU)/0.5ml, Bordetella pertussis (Whole cell) - =16OU (=4.0IU)/0.5ml, HBs Antigen (r DNA)1 - =10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - =1.25mg , 2 conjugated to tetanos toxoid carrier protein -		Injectable suspension	1,515,854 L.L
N02CD02	EMGALITY	BioTech	Galcanezumab - 120mg/ml	120mg/ml	Injectable suspension	37,250,732 L.L
H02AB01	DIPROFOS	B	Betamethasone (dipropionate) - 5mg/ml, Betamethasone (sodium phosphate) - 2mg/ml		Injectable suspension	446,156 L.L
J01DD04	LEBACEF	G	Ceftriaxone - 1g	1g	Injectable sterile powder for solution + lidocaine solvent	508,100 L.L
J01DD04	LEBACEF	G	Ceftriaxone - 1g	1g	Injectable sterile powder for solution + lidocaine solvent	508,100 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	1,135,227 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	21,688,377 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable sterile lyophilised powder for solution	1,695,033 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable sterile lyophilised powder for solution	29,098,108 L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	895,895 L.L

Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 22F, 23F,33F (2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg) Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate adjuvant -